10zyme
10zyme is a UK-based early-stage MedTech startup focused on redefining cervical screening through innovative diagnostic technology. They are developing a self-test that provides instant results for high-risk HPV, the primary cause of cervical cancer. This self-testing solution offers an accessible, convenient, and life-saving cancer prevention method, aiming to increase screening participation and reduce the burden on healthcare resources, contributing to the global elimination of cervical cancer. Their technology integrates artificial intelligence, machine learning, synthetic biology, and biophysics, with a focus on behavioral science and psychology to ensure product inclusivity and accessibility. The company's vision is to empower women to effectively control their cervical health.
10zyme
10zyme is a UK-based early-stage MedTech startup focused on redefining cervical screening through innovative diagnostic technology. They are developing a self-test that provides instant results for high-risk HPV, the primary cause of cervical cancer. This self-testing solution offers an accessible, convenient, and life-saving cancer prevention method, aiming to increase screening participation and reduce the burden on healthcare resources, contributing to the global elimination of cervical cancer. Their technology integrates artificial intelligence, machine learning, synthetic biology, and biophysics, with a focus on behavioral science and psychology to ensure product inclusivity and accessibility. The company's vision is to empower women to effectively control their cervical health.